PharmaResearch Co Ltd
KOSDAQ:214450
Intrinsic Value
The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 410 498.53 KRW. Compared to the current market price of 358 500 KRW, PharmaResearch Co Ltd is Undervalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
PharmaResearch Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
PharmaResearch Co Ltd
Balance Sheet Decomposition
PharmaResearch Co Ltd
Current Assets | 554.5B |
Cash & Short-Term Investments | 437.4B |
Receivables | 56.6B |
Other Current Assets | 60.6B |
Non-Current Assets | 301.2B |
Long-Term Investments | 105.7B |
PP&E | 147.3B |
Intangibles | 33.4B |
Other Non-Current Assets | 14.7B |
Free Cash Flow Analysis
PharmaResearch Co Ltd
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
PharmaResearch Co Ltd
Revenue
|
350.1B
KRW
|
Cost of Revenue
|
-98.9B
KRW
|
Gross Profit
|
251.2B
KRW
|
Operating Expenses
|
-125.2B
KRW
|
Operating Income
|
126.1B
KRW
|
Other Expenses
|
-34B
KRW
|
Net Income
|
92B
KRW
|
Profitability Score
Profitability Due Diligence
PharmaResearch Co Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
Score
PharmaResearch Co Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
PharmaResearch Co Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
PharmaResearch Co Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
PharmaResearch Co Ltd
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 346 800 KRW with a low forecast of 292 900 KRW and a high forecast of 409 500 KRW.
Dividends
Current shareholder yield for PharmaResearch Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 410 498.53 KRW.
Compared to the current market price of 358 500 KRW, PharmaResearch Co Ltd is Undervalued by 13%.